Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Regulatory

    General Controls

    In one line
    Baseline FDA requirements that apply to all medical devices regardless of class.
    Definition
    General Controls include establishment registration, device listing, premarket notification (where required), prohibition of adulteration/misbranding, labeling, GMP/QS requirements, and recordkeeping. They form the floor under every device class. They come from sections 501, 502, 510, 516, 518, 519 and 520 of the FD&C Act, and also cover medical device reporting. For most Class I devices they are the only controls that apply.
    Why it matters
    Class I devices are typically regulated by General Controls alone; Class II adds Special Controls, and Class III requires PMA on top of both.
    Common pitfalls
    • •Assuming that General Controls are only relevant for Class I devices overlooks their universal applicability to all device classes.
    • •Failing to maintain accurate and up-to-date device listings and establishment registrations can lead to significant compliance issues.
    • •Underestimating the importance of robust quality system implementation, even for lower-risk devices, can result in product failures and regulatory actions.
    • •Ignoring labeling requirements, such as those for intended use or contraindications, can misinform users and pose patient risks.
    • •Believing that premarket notification (510(k)) is always exempted for Class I devices is incorrect, as some Class I devices may require it.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.